Surgical instruments, such as ophthalmic knives and skin staplers
Ophthalmic knives
Skin staplers
Eyeless Needle ※Mainly OEM products
Eyeless needles
Eyed needles
Surgical sutures
Dental sutures
Eyeless needles
Eyed needles
Dental/GDF (*)
Dental endodontic instruments
Dental rotary and cutting instruments
GDF(*) / Dental restoration materials
Dental endodontic
Dental rotary and cutting instruments
Dental restoration materials
instruments
(Dia-burs)
(Reamers/ Files)
(*)GDF is the abbreviation for GDF Gesellschaft für dentale Forschung und Innovationen GmbH, a consolidated subsidiary in Germany that produces and sells dental restoration materials
FY2022
Financial Results
Financial Forecasts
Progress in
Supplementary
3
Financial Results and Forecasts
Medium-term
Materials
Management Plan
Agenda
I
FY2022 Financial Results
4
Ⅲ
Progress in Medium-
term Management Plan
Consolidated Financial Results
Outline of the Plan
Sales Status (by Segments and Regions)
Business Model Innovation
Operating Income Status
Financial Targets
Balance Sheet
Review of the First Year
Cash Flow
Future Initiatives
Ⅱ
FY2023 Financial Forecasts
11
IV
Supplementary
Financial Forecasts Overview
Materials
Sales Forecasts
Operating Income Forecasts
Forecast of capital investment and R&D expenses
Dividends
18
28
FY2022
Financial Results
Financial Forecasts
Progress in
Supplementary
4
Financial Results and Forecasts
Medium-term
Materials
Management Plan
FY2022 Financial Results
FY2022
Financial Results
Financial Forecasts
Progress in
Supplementary
5
Financial Results and Forecasts
Medium-term
Materials
Management Plan
FY2022 Consolidated Financial Results
Net sales, operating income and ordinary income have marked the highest figures due to demand recovery in Europe and Asia, and impacts of yen depreciation
Cost of sales ratio deteriorated due to inventory disposal which occurred in 2Q and 3Q. SG&A expenses increased due to enhancement in management systems
Foreign exchange gains increased due to further depreciation of yen since the disclosure of FY2022 revised forecasts on July 8.
FY2021
FY2022
FY2022
YoY
Revised
（¥ million）
Results
Results
%
Amount
%
Forecasts
Net sales
17,190
20,416
+3,226
+18.8%
20,150
+266
+1.3%
Cost of
6,185
7,841
+1,655
+26.8%
7,840
+1
+0.0%
sales
(%)
(36.0%)
(38.4 %)
(38.9%)
SG&A
5,656
6,411
+755
+13.4%
6,160
+251
+4.1%
expenses
(%)
(32.9%)
(31.4%)
(30.6%)
Operating
5,348
6,163
+815
+15.2%
6,150
+13
+0.2%
income
(%)
(31.1%)
(30.2%)
(30.5%)
Ordinary
5,679
7,544
+1,865
+32.8%
7,050
+494
+7.0%
income
Net
4,291
5,290
+999
+23.3%
4,850
+440
+9.1%
income
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Mani Inc. published this content on 11 October 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 October 2022 08:11:03 UTC.
Mani Inc is a Japan-based company mainly engaged in the manufacture and sale of medical equipment. The Company operates through three business segments. The Surgical-related Product segment is engaged in the provision of surgical suture needles and threads, as well as ophthalmic knives, born saws, blood vessel knives and other surgical equipment. The Eyeless Needle-related Product segment is engaged in the provision of eyeless surgical suture needles. The Dental-related Product segment is engaged in the manufacture and sale of dental root canal treatment equipment, such as reamers, files, broaches and cleansers; grinding and abrasive agents, such as carborundum points and silicone points; rotating dental treatment equipment, such as diamond burs, carbide burs, stainless burs and others, as well as dental materials, dental stereomicroscopes, among others.
MANI, INC. 
